ask="1.21"
ask_size="2400"
average_daily_volume="683027"
bid="1.15"
bid_size="2700"
book_value="0.52"
change="+0.01"
change_from_200_day_moving_average="0.15"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-1.17"
change_From_52_week_low="0.65"
change_in_percent="+0.87%"
close="1.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-20.52M"
eps_estimate_current_year="-0.24"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="56757000"
high="1.18"
high_52_weeks="2.33"
last_trade_date="1/6/2017"
last_trade_price="1.16"
last_trade_size="1750"
last_trade_time="4:00pm"
low="1.10"
low_52_weeks="0.51"
market_capitalization="96.13M"
moving_average_200_day="1.01"
moving_average_50_day="1.13"
name="Catalyst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="4.38"
open="1.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.69%"
percent_change_from_50_day_moving_average="+2.79%"
percent_change_from_52_week_high="-50.21%"
percent_change_from_52_week_low="+127.45%"
previous_close="1.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="82870000"
short_ratio="5.12"
stock_exchange="NCM"
symbol="CPRX"
volume="457147"
weeks_range_52="0.51 - 2.33"
